LABFF vs GOOGL: Which Stock is Better?
Side-by-side comparison of Laboratorios Farmaceuticos Rovi, S.A./Adr and Alphabet Inc in 2026
LABFF
Laboratorios Farmaceuticos Rovi, S.A./Adr
$90.61
GOOGL
Alphabet Inc
$338.20
Key Metrics Comparison
| Metric | LABFF | GOOGL | Winner |
|---|---|---|---|
| Market Cap | $4.63B | N/A | LABFF |
| P/E Ratio | 28.95 | 31.06 | LABFF |
| EPS (TTM) | $3.13 | $10.82 | GOOGL |
| Revenue Growth | 0.1% | 0.2% | GOOGL |
| Gross Margin | 63.4% | 59.7% | LABFF |
Analyze LABFF
Full quant analysis
Analyze GOOGL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LABFF or GOOGL a better investment?
Comparing LABFF and GOOGL: Laboratorios Farmaceuticos Rovi, S.A./Adr has a market cap of $4.63B while Alphabet Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LABFF and GOOGL?
LABFF (Laboratorios Farmaceuticos Rovi, S.A./Adr) and GOOGL (Alphabet Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LABFF or GOOGL?
Based on P/E ratios, LABFF trades at a lower multiple (28.9x vs 31.1x).
Which is growing faster: LABFF or GOOGL?
GOOGL has higher revenue growth at 0.2% vs 0.1% for LABFF.
Which company is more profitable: LABFF or GOOGL?
Laboratorios Farmaceuticos Rovi, S.A./Adr (LABFF) has higher gross margins at 63.4% compared to 59.7% for GOOGL.
Which is the larger company: LABFF or GOOGL?
Laboratorios Farmaceuticos Rovi, S.A./Adr (LABFF) is larger with a market cap of $4.63B compared to N/A for GOOGL.
Should I buy LABFF or GOOGL in 2026?
Both LABFF and GOOGL have investment merit. LABFF trades at $90.61 while GOOGL trades at $338.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LABFF and GOOGL stock?
Key differences: Market Cap ($4.63B vs N/A), P/E Ratio (28.9x vs 31.1x), Revenue Growth (0.1% vs 0.2%), Gross Margin (63.4% vs 59.7%).